Status:
COMPLETED
BRAVA: Building Resilience and Attachment in Vulnerable Adolescents
Lead Sponsor:
Children's Hospital of Eastern Ontario
Collaborating Sponsors:
Mach Gaensslen Foundation
Children's Hospital of Eastern Ontario Research Institute
Conditions:
Suicidal Ideation
Suicide and Self-harm
Eligibility:
All Genders
13-17 years
Phase:
NA
Brief Summary
The prevalence of suicidal ideation (SI) among adolescents in North America is high, making it critical to develop evidence-based brief interventions for adolescents with SI that target healthy coping...
Eligibility Criteria
Inclusion
- Adolescents 13 years old to 17.5 years old
- Mild to moderate suicidal ideation (SI without plan or gesture; 1 on the HEADS-ED) (Cappelli, et al., 2012)
- Interested in study participation
- Access to an electronic device with internet and email capabilities, and a functioning camera and microphone
Exclusion
- SI with plan or gesture (2 on HEADS ED; indicated plan or gesture)
- Comorbid disorders (psychosis, schizophrenia, developmental disabilities, major substance abuse, and severe eating disorders).
- Referring clinician has identified an externalizing disorder as a primary diagnosis or primary concern (e.g. Conduct Disorder)
- Currently participating in regular psychotherapy at least one time per week
- Currently under Children's Aid Society care
- Currently in the CHEO ED on a Form 1 or Form 2, or placed on a Section 17.
- Express difficulty with reading and writing
Key Trial Info
Start Date :
April 12 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 25 2023
Estimated Enrollment :
99 Patients enrolled
Trial Details
Trial ID
NCT04751968
Start Date
April 12 2021
End Date
August 25 2023
Last Update
May 6 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHEO
Ottawa, Ontario, Canada, K1H 8L1